A Rapamycin-Based GMP-Compatible Process for the Isolation and Expansion of Regulatory T Cells for Clinical Trials. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2018.01.006
PubMed Identifier: 29552576
Publication URI: http://europepmc.org/abstract/MED/29552576
Type: Journal Article/Review
Volume: 8
Parent Publication: Molecular therapy. Methods & clinical development
ISSN: 2329-0501